CN110129179A - A kind of three joint bag and the method using three joint bag separation umbilical cord blood hematopoietic stem cell - Google Patents

A kind of three joint bag and the method using three joint bag separation umbilical cord blood hematopoietic stem cell Download PDF

Info

Publication number
CN110129179A
CN110129179A CN201910457872.3A CN201910457872A CN110129179A CN 110129179 A CN110129179 A CN 110129179A CN 201910457872 A CN201910457872 A CN 201910457872A CN 110129179 A CN110129179 A CN 110129179A
Authority
CN
China
Prior art keywords
bag
blood
connecting tube
cord blood
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201910457872.3A
Other languages
Chinese (zh)
Inventor
丁海雷
黄冠
成玉萍
孙三勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU BEIKE BIO-TECHNOLOGY Co Ltd
Original Assignee
JIANGSU BEIKE BIO-TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU BEIKE BIO-TECHNOLOGY Co Ltd filed Critical JIANGSU BEIKE BIO-TECHNOLOGY Co Ltd
Priority to CN201910457872.3A priority Critical patent/CN110129179A/en
Publication of CN110129179A publication Critical patent/CN110129179A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/04Cell isolation or sorting
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0647Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Sustainable Development (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention establishes a kind of three joint bag and the method using three joint bag separation umbilical cord blood hematopoietic stem cell, this method isolates candidate stem cell by the way of three joint bag from Cord blood, the whole operation process of three joint bag separation is completed in the environment of closed sterile soft, both the pollution of operating process can have been reduced, it is low to the sterility requirements of operating environment and personnel simultaneously, convenient for operation;Using automatic plasma separating folder removal blood plasma, speed is fast for separation process, easy to operate, improves operating efficiency.

Description

A kind of three joint bag and the method using three joint bag separation umbilical cord blood hematopoietic stem cell
Technical field
The present invention relates to a kind of three joint bag and the methods of application three joint bag separation umbilical cord blood hematopoietic stem cell, belong to navel The technical field of extraction with blood candidate stem cell.
Background technique
Candidate stem cell (hemopoietic stem cell) refers to the cell that a group is not yet reached maturity, and is all make The origin of haemocyte and immunocyte, it can not only be divided into red blood cell, leucocyte and blood platelet, can be with cross-system point The cell of various histoorgans is turned to, there is self-renewing, Multidirectional Differentiation and goes back to the nest (i.e. directional migration to hematopoietic tissue organ) Potential, belong to multipotential stem cell.Research finds that candidate stem cell can treat a variety of diseases, with the development of medicine, hematopoiesis Stem cell transplantation has become the main means of the diseases in the blood system such as radical cure leukaemia at present, brings for mankind's Fighting Disease New hope.
After Cord blood is delivery of baby, remains in the blood in placenta and umbilical cord, be usually to pass into disuse.But it is close several 10 years the study found that containing can rebuild the candidate stem cell of human body hematopoiesis and immune system in Cord blood, and quantity compared with It is more.Therefore, Cord blood has become coming for the candidate stem cell of the important sources of candidate stem cell, especially consanguinity-less relation Source is also very important human biological's resource.Candidate stem cell is isolated from Cord blood at present and there is open behaviour by hand Make contamination probability height, environmental requirement is high, it is complicated for operation the problems such as;Automatic separation system has simple and convenient, but separation costs are high The shortcomings that, therefore find that a kind of operating process contamination probability is low, and environmental requirement is low, separation method tool easy to operate, at low cost It is significant.
Summary of the invention
The present invention is in view of the above-mentioned problems, separate umbilical cord blood hematopoietic to propose a kind of three joint bag and application three joint bag The method of stem cell.
Specific technical solution is as follows:
A kind of three joint bag, including prepare bag, plasma bags and freeze bag, wherein it prepares and is respectively equipped with the first connection on bag Pipe, the 4th connecting tube and the 5th connecting tube;
First connecting tube is connected with second pipe and third pipeline respectively, and the first connecting tube is equipped with the first sample tap, Second connecting tube is connected with blood transfusion puncture outfit, and third connecting tube is connected with plasma bags, and third connecting tube is equipped with second and takes Sample mouth;
4th connecting tube is connected with bag is frozen;
5th connecting tube is connected with frozen stock solution mouth is added;
Second connecting tube is equipped with first clamp, the 4th connecting tube is equipped with second clamp, the 5th connecting tube is equipped with the Three clips, third connecting tube are equipped with the 4th clip.
Using the method for above-mentioned three joint bag separation umbilical cord blood hematopoietic stem cell, comprising the following steps:
1) it is put into after sterilizing three joint bag in Biohazard Safety Equipment, empties plasma bags and freezes the air in bag, closed all Clip;
2) the blood transfusion puncture outfit of three joint bag is penetrated into the turncap open end of blood taking bag and tightened;
3) blood taking bag is lifted, first clamp is unclamped, prepares blood inflow in blood taking bag in bag, is closed after the completion of transfer First clamp, will prepare bag and is placed on shaking table and shake up 5min;
4) it is mixed after ready hydroxyethyl starch being prepared bag by the first sample tap injection;
5) the preparation bag equipped with Cord blood is clamped with the transfering bag after two inflations and is fixed in Centrifuge Cup, after trim It is placed in centrifuge and is centrifuged 50g, 7min, 10 DEG C;
6) after being centrifuged, Centrifuge Cup is taken out, then taking-up prepares bag from Centrifuge Cup, clamps first clamp with haemostatic clamp Neighbouring pipeline hangs upside down and stands 5min;
7) after being layered clearly, first clamp is opened, red blood cell velocity is controlled with haemostatic clamp, makes red blood cell with 3-10ml/ The speed of min flows into blood taking bag, until layering interfaces distance is prepared at bag nozzle 1cm, clamps haemostatic clamp, closes the first folder Son, removes preparation bag, and heat seal is fallen to connect the pipeline of blood taking bag;
8) blood in preparation bag is mixed, is clamped with the transfering bag after two inflations and prepares bag fixed in Centrifuge Cup, It is placed in after trim in centrifuge and is centrifuged 747g, 15min, 10 DEG C;
9) after being centrifuged, Centrifuge Cup is taken out, then taking-up prepares bag from Centrifuge Cup, is linked into the automatic plasma separating of 21 ± 1ml In folder, the 4th clip is opened, presses the switch of automatic plasma separating folder, extra blood plasma can be squeezed at the uniform velocity in plasma bags, arrived automatic It is automatically stopped after plasma-separating clip setting 21 ± 1ml of volume;
10) the 4th clip is closed, removes preparation bag from automatic plasma separating folder, the blood plasma in pipeline is passed through the 4th clip It squeezes into plasma bags manually, heat seal plasma bags and prepares pipeline between bag, it is stand-by to cut plasma bags;
11) bag surface is prepared with non-dust cloth wiping, it is ensured that be attached to the karyocyte prepared on bag inner wall and fully enter blood Liquid, mix deshydremia after from the first sample tap take 1ml blood sample carry out cell number, motility rate, surface marker and colony CFU detection;
12) preparation bag is clamped with biology ice bag, is put into 4-10 DEG C of drug storage box and at least 20min is pre-chilled;
13) open third clip, with micro-injection pump by the frozen stock solution of pre-cooling from adding frozen stock solution mouth addition to prepare in bag, Third clip is closed after adding;
14) after frozen stock solution adds, second clamp is opened, the mixed liquor prepared in bag is transferred to and is frozen in bag, drains and freezes Air in bag makes deshydremia mixed liquor is full to freeze a bag pipeline, and heat seal is fallen to freeze the pipeline of bag, will freeze bag and is put into program Program cooling freezing is carried out in cooling instrument;
15) 16ml blood plasma is taken to carry out aerobic bacteria and anaerobic bacteria detection from the second sample tap of plasma bags.
Further, the additional amount of the hydroxyethyl starch in step 1) are as follows: Cord blood net weight=Cord blood gross weight-sky is adopted Blood bag weight, Cord blood net volume=Cord blood net weight/1.03, hydroxyethyl starch volume=Cord blood net volume × 0.2.
Further, the preparation bag upside down equipped with Cord blood in step 5) is in Centrifuge Cup.
Further, the preparation bag of step 8), which is just put, is placed in Centrifuge Cup.
Further, in step 13), in preparing bag plus during the entire process of frozen stock solution, bag is prepared all by biological ice bag It clamps, and is placed on micro computer and adopts and shaken up on fluid controller.
Further, the volume ratio of frozen stock solution addition are as follows: deshydremia: frozen stock solution=4:1, frozen stock solution is by dextran It is formed with two kinds of reagents of DMSO according to the volume ratio mixed preparing of 1:1.
The invention has the benefit that
1) Cord blood separation overall process all carries out in the environment of closed sterile soft, reduces the probability of sample contamination;
2) removal blood plasma is pressed from both sides with automatic plasma separating, speed is fast, and it is easy to operate, improve efficiency;
3) separation process removes red blood cell using gravity using centrifugation is inverted, convenient at the uniform velocity to control.
Detailed description of the invention
Fig. 1 is three joint bag structural schematic diagram of the present invention;
Fig. 2 is 4 surface marker streaming figure of sample of the present invention;
Fig. 3 is 4 survival rate test result figure of sample of the present invention;
Fig. 4 is 4 granulocytes of sample of the present invention-erythroid cells-macrophage-megakaryocyte Colony forming figure;
Fig. 5 is the quick-fried formula erythroid cells Colony forming figure of sample of the present invention 4;
Fig. 6 is that 4 granulocyte-macrophage colony of sample of the present invention forms figure.
In Fig. 2: All Events is all detection cells randomly selected;P1 is expression CD45 sun in detection cell The cell of property;P2 is to express the cell of the CD34 positive from P1;P3 is to express the cell of CD45 weakly positive from P2; P4 derives from P3, expresses the cell of the CD34 positive.
Appended drawing reference:
It prepares bag 1, plasma bags 2, freeze bag 3, the first connecting tube 4, the 4th connecting tube 5, the 5th connecting tube 6, second pipe 7, third pipeline 8, the first sample tap 9, blood transfusion puncture outfit 10, the second sample tap 11, frozen stock solution mouth 12, first clamp 13, second Clip 14, third clip 15, the 4th clip 16.
Specific embodiment
Clear to be more clear technical solution of the present invention, the present invention is described further with reference to the accompanying drawing, The technical characteristic of any pair of technical solution of the present invention carries out the scheme that equivalencing is obtained with conventional reasoning and each falls within guarantor of the present invention Protect range.
Embodiment one
A kind of three joint bag as shown in Figure 1, including prepare bag 1, plasma bags 2 and freeze bag 3, wherein it prepares and is set respectively on bag There are the first connecting tube 4, the 4th connecting tube 5 and the 5th connecting tube 6;
First connecting tube is connected with second pipe 7 and third pipeline 8 respectively, and the first connecting tube is equipped with the first sampling Mouth 9, the second connecting tube are connected with blood transfusion puncture outfit 10, and third connecting tube is connected with plasma bags, and third connecting tube is equipped with Second sample tap 11;
4th connecting tube is connected with bag is frozen;
5th connecting tube is connected with frozen stock solution mouth 12 is added;
Second connecting tube is equipped with first clamp 13, the 4th connecting tube is equipped with second clamp 14, sets in the 5th connecting tube There are third clip 15, third connecting tube to be equipped with the 4th clip 16.
Embodiment two
The method of the three joint bag separation umbilical cord blood hematopoietic stem cell of Application Example one, comprising the following steps:
1) three joint bag is taken, with being put into Biohazard Safety Equipment behind 75% alcohol disinfecting surface, empties plasma bags and jelly The air in bag is deposited, all clips are closed, bag, plasma bags is being prepared and is freezing labelled on bag;
2) the blood transfusion puncture outfit needle cap of three joint bag is pulled up, puncture penetrates blood taking bag turncap open end and tightens;
3) blood taking bag is lifted, first clamp is unclamped, prepares blood inflow in blood taking bag in bag, is closed after the completion of transfer First clamp, will prepare bag and is placed on shaking table and shake up 5min;
4) hydroxyethyl starch volume: hydroxyethyl starch volume=(Cord blood gross weight-sky blood taking bag weight is calculated according to formula Amount) ÷ 1.03 × 0.2, it is softly mixed after ready hydroxyethyl starch is prepared bag by the first sample tap injection;
5) the preparation bag equipped with Cord blood is clamped with the transfering bag after two inflations, upside down is fixed on centrifugation In cup, it is placed in after trim in centrifuge and is centrifuged 50g, 7min, 10 DEG C;
6) after being centrifuged, Centrifuge Cup is taken out, then taking-up prepares bag from Centrifuge Cup, clamps first clamp with haemostatic clamp Neighbouring pipeline, hangs upside down in Biohazard Safety Equipment, stands 5min;
7) after being layered clearly, first clamp is opened, red blood cell velocity is controlled with haemostatic clamp, makes red blood cell with 3-10ml/ The speed of min flows into blood taking bag, until layering interfaces distance is prepared at bag nozzle 1cm, clamps haemostatic clamp, closes the first folder Son, removes preparation bag, and heat seal is fallen to connect the pipeline of blood taking bag;
8) blood in preparation bag is mixed, clamps preparation bag with the transfering bag after two inflations, stands the fixation of placement It is placed in into Centrifuge Cup, after trim in centrifuge and is centrifuged 747g, 15min, 10 DEG C;
9) after being centrifuged, Centrifuge Cup is taken out, then taking-up prepares bag from Centrifuge Cup, is linked into the automatic plasma separating of 21 ± 1ml In folder, the 4th clip is opened, presses the switch of automatic plasma separating folder, extra blood plasma can be squeezed at the uniform velocity in plasma bags, arrived automatic It is automatically stopped after plasma-separating clip setting 21 ± 1ml of volume;
10) the 4th clip is closed, removes preparation bag from automatic plasma separating folder, the blood plasma in pipeline is passed through the 4th clip It squeezes into plasma bags manually, heat seal plasma bags and prepares pipeline between bag, it is stand-by to cut plasma bags;
11) three joint bag is put into Biohazard Safety Equipment, prepares bag surface with non-dust cloth wiping, it is ensured that be attached to and prepare in bag Karyocyte on wall fully enters blood, sterilizes the first sample tap with cotton ball soaked in alcohol, mixes after deshydremia from the first sample tap 1ml blood sample is taken to carry out cell number, motility rate, surface marker and colony CFU detection;The testing result of cell number is 11.8 × 108 (cell number is 13.0 × 10 before separating8), according to rate of recovery calculation: the rate of recovery=(karyocyte total number of cells after separation Total number of nucleated cell before ÷ is separated) × 100%, the rate of recovery 90.8%;With flow cytomery CD34+ cell, detection knot Fruit is that the percentage that CD34+ cell occupies nucleus is 0.12%;Candidate stem cell passes through 14 culture, sees under the microscope Observe the different candidate stem cell Colony formings such as red system, grain system.
12) preparation bag is clamped with biology ice bag, is put into 4-10 DEG C of drug storage box and at least 20min is pre-chilled;
13) two kinds of reagents of dextran and DMSO are put into 4-10 DEG C of medicine according to the ratio mixed preparing frozen stock solution of 1:1 At least 20min is pre-chilled in product storage box;Third clip is opened, according to deshydremia: frozen stock solution=4:1 ratio uses micro-injection The frozen stock solution of pre-cooling from adding frozen stock solution mouth addition to prepare in bag, during the entire process of adding frozen stock solution, is prepared bag all by biology by pump Ice bag is clamped, and is placed on micro computer and is adopted and shaken up on fluid controller, and third clip is closed after adding;
14) after frozen stock solution adds, second clamp is opened, the mixed liquor prepared in bag is transferred to and is frozen in bag, drains and freezes Air in bag makes deshydremia mixed liquor is full to freeze a bag pipeline, and heat seal is fallen to freeze the pipeline of bag, will freeze bag and is put into 25ml It freezes in can, is then placed in programmed cooling instrument and carries out program cooling freezing;
15) 16ml blood plasma is taken to carry out aerobic bacteria and anaerobic bacteria detection from the second sample tap of plasma bags with 20ml syringe.
Embodiment three
The result for taking the sample of 5 cord blood candidate stem cells to separate through three joint bag is as follows:
By taking sample 4 as an example, attached drawing 2-6 enumerates corresponding testing result figure.
The foregoing is only a preferred embodiment of the present invention, but scope of protection of the present invention is not limited thereto, In the technical scope disclosed by the present invention, any changes or substitutions that can be easily thought of by anyone skilled in the art, It should all cover in protection scope of the present invention.

Claims (7)

1. a kind of three joint bag, it is characterized in that, including prepare bag, plasma bags and freeze bag, wherein it prepares and is respectively equipped with first on bag Connecting tube, the 4th connecting tube and the 5th connecting tube;
First connecting tube is connected with second pipe and third pipeline respectively, the first connecting tube be equipped with the first sample tap, second Connecting tube is connected with blood transfusion puncture outfit, and third connecting tube is connected with plasma bags, and third connecting tube is equipped with the second sample tap;
4th connecting tube is connected with bag is frozen;
5th connecting tube is connected with frozen stock solution mouth is added;
Second connecting tube is equipped with first clamp, the 4th connecting tube is equipped with second clamp, the 5th connecting tube is pressed from both sides equipped with third Son, third connecting tube are equipped with the 4th clip.
2. the method for application three joint bag as described in claim 1 separation umbilical cord blood hematopoietic stem cell, it is characterized in that, including it is following Step:
1) it is put into after sterilizing three joint bag in Biohazard Safety Equipment, empties plasma bags and freezes the air in bag, close all clips;
2) the blood transfusion puncture outfit of three joint bag is penetrated into the turncap open end of blood taking bag and tightened;
3) blood taking bag is lifted, first clamp is unclamped, prepares blood inflow in blood taking bag in bag, the first folder is closed after the completion of transfer Son, will prepare bag and is placed on shaking table and shake up 5min;
4) it is mixed after ready hydroxyethyl starch being prepared bag by the first sample tap injection;
5) the preparation bag equipped with Cord blood is clamped with the transfering bag after two inflations and is fixed in Centrifuge Cup, is placed in after trim 50g, 7min, 10 DEG C are centrifuged in centrifuge;
6) after being centrifuged, Centrifuge Cup is taken out, then taking-up prepares bag from Centrifuge Cup, clamps first clamp with haemostatic clamp and nearby manages Road hangs upside down and stands 5min;
7) after being layered clearly, first clamp is opened, red blood cell velocity is controlled with haemostatic clamp, makes red blood cell with 3-10ml/min's Speed flows into blood taking bag, until layering interfaces distance is prepared at bag nozzle 1cm, clamps haemostatic clamp, closes first clamp, remove Bag is prepared, heat seal is fallen to connect the pipeline of blood taking bag;
8) blood in preparation bag is mixed, is clamped with the transfering bag after two inflations and prepares bag fixed in Centrifuge Cup, trim After be placed in centrifuge and be centrifuged 747g, 15min, 10 DEG C;
9) after being centrifuged, Centrifuge Cup is taken out, then taking-up prepares bag from Centrifuge Cup, is linked into the automatic plasma separating folder of 21 ± 1ml, The 4th clip is opened, the switch of automatic plasma separating folder is pressed, extra blood plasma can be squeezed at the uniform velocity in plasma bags, and automatic plasma separating folder has been arrived It is automatically stopped after setting 21 ± 1ml of volume;
10) the 4th clip is closed, removes preparation bag from automatic plasma separating folder, the blood plasma in pipeline is squeezed manually by the 4th clip Enter in plasma bags, heat seal plasma bags and prepare pipeline between bag, it is stand-by to cut plasma bags;
11) bag surface is prepared with non-dust cloth wiping, it is ensured that be attached to the karyocyte prepared on bag inner wall and fully enter blood, mix 1ml blood sample is taken to carry out cell number, motility rate, surface marker and colony CFU detection from the first sample tap after deshydremia;
12) preparation bag is clamped with biology ice bag, is put into 4-10 DEG C of drug storage box and at least 20min is pre-chilled;
13) open third clip, with micro-injection pump by the frozen stock solution of pre-cooling from adding frozen stock solution mouth addition to prepare in bag, after adding Close third clip;
14) after frozen stock solution adds, second clamp is opened, the mixed liquor prepared in bag is transferred to and is frozen in bag, drains and freezes in bag Air, make deshydremia mixed liquor is full to freeze a bag pipeline, heat seal is fallen to freeze the pipeline of bag, will freeze bag and is put into programmed cooling instrument Middle progress program cooling freezing;
15) 16ml blood plasma is taken to carry out aerobic bacteria and anaerobic bacteria detection from the second sample tap of plasma bags.
3. as claimed in claim 2 using the method for three joint bag separation umbilical cord blood hematopoietic stem cell, it is characterized in that in step 1) Hydroxyethyl starch additional amount are as follows: Cord blood net weight=Cord blood gross weight-sky blood taking bag weight, Cord blood net volume=umbilical cord Blood net weight/1.03, hydroxyethyl starch volume=Cord blood net volume × 0.2.
4. being equipped with navel in step 5) as claimed in claim 3 using the method for three joint bag separation umbilical cord blood hematopoietic stem cell Preparation bag upside down with blood is in Centrifuge Cup.
5. the preparation bag of step 8) is just as claimed in claim 4 using the method for three joint bag separation umbilical cord blood hematopoietic stem cell Storing is placed in Centrifuge Cup.
6. in step 13), being prepared using the method for three joint bag separation umbilical cord blood hematopoietic stem cell as claimed in claim 5 It in bag plus during the entire process of frozen stock solution, prepares bag and is all clamped by biological ice bag, and be placed on micro computer to adopt fluid controller enterprising Row shakes up.
7. as claimed in claim 6 using the method for three joint bag separation umbilical cord blood hematopoietic stem cell, frozen stock solution adding proportion is Deshydremia: frozen stock solution=4:1, frozen stock solution are formed by two kinds of reagents of dextran and DMSO according to the ratio mixed preparing of 1:1.
CN201910457872.3A 2019-05-29 2019-05-29 A kind of three joint bag and the method using three joint bag separation umbilical cord blood hematopoietic stem cell Withdrawn CN110129179A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910457872.3A CN110129179A (en) 2019-05-29 2019-05-29 A kind of three joint bag and the method using three joint bag separation umbilical cord blood hematopoietic stem cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910457872.3A CN110129179A (en) 2019-05-29 2019-05-29 A kind of three joint bag and the method using three joint bag separation umbilical cord blood hematopoietic stem cell

Publications (1)

Publication Number Publication Date
CN110129179A true CN110129179A (en) 2019-08-16

Family

ID=67582680

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910457872.3A Withdrawn CN110129179A (en) 2019-05-29 2019-05-29 A kind of three joint bag and the method using three joint bag separation umbilical cord blood hematopoietic stem cell

Country Status (1)

Country Link
CN (1) CN110129179A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110229788A (en) * 2019-04-11 2019-09-13 广州市天河诺亚生物工程有限公司 A kind of preparation method of cord blood mononuclear cells
CN112481098A (en) * 2020-12-11 2021-03-12 深圳市北科生物科技有限公司 Four-in-one bag for separating and storing peripheral blood immune cells and separation method
CN115486440A (en) * 2022-10-20 2022-12-20 许艳杰 Integrated into one piece connects cryopreserved bag verifying attachment

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070062885A1 (en) * 2003-04-30 2007-03-22 Cesare Strisino Method and apparatus for fractionating blood
CN102337245A (en) * 2011-08-02 2012-02-01 江苏省北科生物科技有限公司 Method for separating hemopoietic stem cells through cord blood separation double bag
EP2889047A1 (en) * 2013-12-27 2015-07-01 Evo3medica International GmbH Sterile blood bag system for medical taking and cryopreserving of blood from an umbilical cord
CN205145225U (en) * 2015-11-19 2016-04-13 陕西干细胞工程有限公司 Multipurpose blood cell collection separation suit
CN106999518A (en) * 2014-11-14 2017-08-01 日本赤十字社 The Cryopreservation method and Cryopreservation solution of Cord blood and peripheral blood
CN206814738U (en) * 2017-05-27 2017-12-29 云南新生命干细胞有限公司 A kind of cord blood stem cell separator

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070062885A1 (en) * 2003-04-30 2007-03-22 Cesare Strisino Method and apparatus for fractionating blood
CN102337245A (en) * 2011-08-02 2012-02-01 江苏省北科生物科技有限公司 Method for separating hemopoietic stem cells through cord blood separation double bag
EP2889047A1 (en) * 2013-12-27 2015-07-01 Evo3medica International GmbH Sterile blood bag system for medical taking and cryopreserving of blood from an umbilical cord
CN106999518A (en) * 2014-11-14 2017-08-01 日本赤十字社 The Cryopreservation method and Cryopreservation solution of Cord blood and peripheral blood
CN205145225U (en) * 2015-11-19 2016-04-13 陕西干细胞工程有限公司 Multipurpose blood cell collection separation suit
CN206814738U (en) * 2017-05-27 2017-12-29 云南新生命干细胞有限公司 A kind of cord blood stem cell separator

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110229788A (en) * 2019-04-11 2019-09-13 广州市天河诺亚生物工程有限公司 A kind of preparation method of cord blood mononuclear cells
CN112481098A (en) * 2020-12-11 2021-03-12 深圳市北科生物科技有限公司 Four-in-one bag for separating and storing peripheral blood immune cells and separation method
CN115486440A (en) * 2022-10-20 2022-12-20 许艳杰 Integrated into one piece connects cryopreserved bag verifying attachment

Similar Documents

Publication Publication Date Title
US6268119B1 (en) Method for separating cells
CN110129179A (en) A kind of three joint bag and the method using three joint bag separation umbilical cord blood hematopoietic stem cell
EP1893253B1 (en) Integrated system for collecting, processing and transplanting cell subsets, including adult stem cells, for regenerative medicine
KR101307672B1 (en) Method for controlling propagation of umbilical cord blood hematopoietic stem cells and use thereof
CN101560495A (en) Method and device for separating single karyocyte
CN107058224A (en) A kind of candidate stem cell using placenta as source is extracted and cryopreservation methods
US11745182B2 (en) Collapsible centrifugation vial system and method
CN101707891A (en) Stem cell and progenitor cell composition from marrow or Cord blood recovery; Be used to prepare its system and method
JP2010507389A (en) Medical kit and method of using the same
CN103451151A (en) Method for culturing human umbilical cord mesenchymal stem cells
CN104667362A (en) Full-automatic whole blood collection separator and matched disposable collecting-separating device
CN208876559U (en) A kind of full-automatic whole blood acquisition separation system
CN103484365B (en) A kind of devices and methods therefor obtaining stem cell from tissue
WO2004096319A1 (en) Method and apparatus for fractionating blood
CN202497449U (en) Three-combination bag used for collection, separation and preservation of umbilical cord blood
CN204601195U (en) Bag for collecting cord blood
JP2015012837A (en) Method for producing cell concentrate
CN202170342U (en) Cord blood separation bigeminal bag
CN209529793U (en) A kind of full-automatic whole blood acquisition separation system
JP4162128B2 (en) Sample for cytodiagnosis, preparation method and apparatus thereof
CN209019542U (en) It is a kind of to acquire the device separated with ingredient for bleeding of the umbilicus, placental blood and peripheral blood
CN202892429U (en) Blood bag for density gradient centrifugation of mononuclear cells
CN111254113A (en) Method for extracting placenta hematopoietic stem cells
CN205569837U (en) A static separating bracket for fat transplantation
CN210809006U (en) A cryopreserved bag for cell culture

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20190816